1. Home
  2. ADXN vs SPGC Comparison

ADXN vs SPGC Comparison

Compare ADXN & SPGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • SPGC
  • Stock Information
  • Founded
  • ADXN 2002
  • SPGC 2018
  • Country
  • ADXN Switzerland
  • SPGC United States
  • Employees
  • ADXN N/A
  • SPGC N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • SPGC
  • Sector
  • ADXN Health Care
  • SPGC
  • Exchange
  • ADXN Nasdaq
  • SPGC Nasdaq
  • Market Cap
  • ADXN 11.3M
  • SPGC 7.4M
  • IPO Year
  • ADXN N/A
  • SPGC 2023
  • Fundamental
  • Price
  • ADXN $10.30
  • SPGC $1.89
  • Analyst Decision
  • ADXN Strong Buy
  • SPGC
  • Analyst Count
  • ADXN 1
  • SPGC 0
  • Target Price
  • ADXN $30.00
  • SPGC N/A
  • AVG Volume (30 Days)
  • ADXN 22.8K
  • SPGC 147.2K
  • Earning Date
  • ADXN 11-11-2024
  • SPGC 11-07-2024
  • Dividend Yield
  • ADXN N/A
  • SPGC N/A
  • EPS Growth
  • ADXN N/A
  • SPGC N/A
  • EPS
  • ADXN 0.05
  • SPGC N/A
  • Revenue
  • ADXN $960,641.00
  • SPGC $1,375,000.00
  • Revenue This Year
  • ADXN N/A
  • SPGC $771.92
  • Revenue Next Year
  • ADXN N/A
  • SPGC $76.31
  • P/E Ratio
  • ADXN $1.75
  • SPGC N/A
  • Revenue Growth
  • ADXN N/A
  • SPGC 530.73
  • 52 Week Low
  • ADXN $5.00
  • SPGC $1.59
  • 52 Week High
  • ADXN $27.90
  • SPGC $10.00
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 54.08
  • SPGC 34.12
  • Support Level
  • ADXN $10.04
  • SPGC $1.59
  • Resistance Level
  • ADXN $10.81
  • SPGC $2.10
  • Average True Range (ATR)
  • ADXN 0.59
  • SPGC 0.24
  • MACD
  • ADXN 0.04
  • SPGC -0.10
  • Stochastic Oscillator
  • ADXN 70.88
  • SPGC 12.52

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About SPGC Sacks Parente Golf Inc.

Sacks Parente Golf Inc is a technology-forward golf company, with a growing portfolio of golf products, including putting instruments, golf shafts, golf grips, and other golf-related products. It designs, manufactures, and sells technology-forward, golf equipment, which is comprised of putting instruments, golf shafts, golf grips, and related product groups. It designs its golf products to fit golfers of all skill levels, amateur and professional. Its business segments currently include, golf putting instruments, golf shafts, and golf related products.

Share on Social Networks: